[PDF][PDF] 穩定缺血性心臟病初始保守或介入性管理策略: 我們準備從ISCHEMIA 試驗學習到甚麼
陳朝欽， 雷孟桓 - 內科學誌, 2021 - tsim.org.tw
摘要缺血性心臟病是全世界的主要死亡和致殘原因. 所有患有穩定缺血性心臟病(SIHD)
的患者都應接受最佳藥物治療, 藉以減少動脈粥狀硬化的進展並防止冠狀動脈血栓 …
的患者都應接受最佳藥物治療, 藉以減少動脈粥狀硬化的進展並防止冠狀動脈血栓 …
Quantitative coronary physiology for clinical management: the imaging standard
KL Gould, NP Johnson - Current cardiology reports, 2016 - Springer
Pressure derived FFR and coronary flow capacity by PET define a physiologic severity-risk-
benefit continuum wherein probability of benefit from revascularization over risk of the …
benefit continuum wherein probability of benefit from revascularization over risk of the …
Popular procedures without evidence of benefit: A case study of percutaneous coronary intervention for stable coronary artery disease
V Guduguntla, RF Redberg - European Journal of Internal Medicine, 2021 - Elsevier
Despite limited benefit, percutaneous coronary intervention (PCI) remains a common
procedure that is often performed for uncertain or inappropriate indications in patients with …
procedure that is often performed for uncertain or inappropriate indications in patients with …
[HTML][HTML] Метаболические миокардиальные цитопротекторы в терапии стабильной ишемической болезни сердца: доказательства эффективности и …
НБ Перепеч - Медицинский совет, 2017 - cyberleninka.ru
В обзоре обсуждаются механизмы действия метаболических миокардиальных
цитопротекторов и рекомендации по их применению в составе фармакотерапии …
цитопротекторов и рекомендации по их применению в составе фармакотерапии …
[HTML][HTML] Stable angina pectoris: which drugs or combinations to use in which patients
MS Kallistratos, LE Poulimenos… - E-Journal of Cardiology …, 2017 - escardio.org
Management of stable angina is often challenging. Despite several therapeutic approaches,
including revascularisation, many patients are symptomatic and their daily activities and …
including revascularisation, many patients are symptomatic and their daily activities and …
Almanac 2011: stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology
RA Henderson, AD Timmis - Heart, 2011 - heart.bmj.com
STABLE ANGINA PECTORIS Diagnostic strategies The widespread application of specialist
clinics for early evaluation of patients with chest pain has focused attention on the …
clinics for early evaluation of patients with chest pain has focused attention on the …
Antianginal efficacy and tolerability of ranolazine as an add-on drug to concomitant medications primarily metoprolol in chronic stable angina patients: A prospective …
Objective: To determine the adverse drug reaction (ADR) profile of risperidone and their
association with dopamine (DRD2− 141 C Ins/Del/rs1799732) and serotonin receptor …
association with dopamine (DRD2− 141 C Ins/Del/rs1799732) and serotonin receptor …
NSCLC, 201410
LN Chronic - BMJ, 2022 - ebm.bmj.com
Appendix 1. Formula used to calculate ROR Appendix 2. Stata codes used the mixed-effects
random intercept linear regression mode Page 1 Appendix 1. Formula used to calculate …
random intercept linear regression mode Page 1 Appendix 1. Formula used to calculate …
[PDF][PDF] Дистанционное наблюдение за пациентами со стабильной стенокардией, перенесшими коронарное стентирование
АК ОСОКИНА - Москва, 2021 - expert-mik.ru
Стентирование коронарных артерий является сегодня наиболее частым
вмешательством, проводимым для лечения ишемической болезни сердца (ИБС)[252; …
вмешательством, проводимым для лечения ишемической болезни сердца (ИБС)[252; …
[PDF][PDF] Perkutane Koronarinterventionen zusätzlich zur optimalen medikamentösen Therapie bei stabiler Angina Pectoris
V Gorenoi, MP Schonermark… - GMS Health Technol …, 2011 - portal.dimdi.de
Bei der medizinischen Bewertung werden zunächst systematische Übersichten von
randomisierten kontrollierten Studien (RCT) ausgewertet. Danach werden RCT mit aktuell …
randomisierten kontrollierten Studien (RCT) ausgewertet. Danach werden RCT mit aktuell …